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ABSTRACT
Objective To determine if general practitioner rates of
antidepressant drugprescribingand referrals to specialist
services fordepressionvary in linewithpatients’ scoreson
depression severity questionnaires.
Design Analysis of anonymised medical record data.
Setting 38 general practices in three sites—
Southampton, Liverpool, and Norfolk.
Data reviewed Records for 2294 patients assessed with
severity questionnaires for depression between April
2006 and March 2007 inclusive.
Main outcome measures Rates of prescribing of
antidepressants and referrals to specialist mental health
or social services.
Results 1658 patients were assessed with the 9 item
patient health questionnaire (PHQ-9), 584 with the
depression subscale of the hospital anxiety and
depression scale (HADS), and 52 with the Beck
depression inventory, 2nd edition (BDI-II). Overall, 79.1%
of patients assessedwith either PHQ-9 orHADS received a
prescription for an antidepressant, and 22.8% were
referred to specialist services. Prescriptions and referrals
were significantly associated with higher severity scores.
However, overall rates of treatment and referral were
similar for patients assessed with either measure despite
the fact that, with PHQ-9, 83.5% of patients were
classified as moderately to severely depressed and in
need of treatment, whereas only 55.6% of patients were
so classified with HADS. Rates of treatment were lower for
older patients and for patients with comorbid physical
illness (including coronary heart disease and diabetes)
despite the fact that screening for depression among such
patients is encouraged in the quality and outcomes
framework.
Conclusions General practitioners do not decide on drug
treatment or referral for depression on the basis of
questionnaire scores alone, but also take account of other
factors such as age and physical illness. The two most
widely used severity questionnaires perform
inconsistently in practice, suggesting that changing the
recommended threshold scores for intervention might
make the measures more valid, more consistent with
practitioners’ clinical judgment, and more acceptable to
practitioners as a way of classifying patients.
INTRODUCTION
SinceApril 2006 theUnitedKingdomgeneral practice
contract quality and outcomes framework (QOF) has
provided incentives to general practitioners tomeasure
the severity of depression with a validated question-
naire at the start of treatment in all diagnosed cases.1
The aim is to improve the targeting of treatment,
particularly antidepressants, to patients with moderate
to severe depression, in line with guidelines.2 3 The
rationale is that doctors’ global assessments of depres-
sion severity do not agree well with valid and reliable
self reported measures of severity in terms of cut-off
levels for case identification,4-7 resulting in overtreat-
ment of mild cases and undertreatment of moderate to
severe cases.7 8
The three recommended measures of depression
severity are the 9 item patient health questionnaire
(PHQ-9),9 the depression subscale of the hospital
anxiety and depression scale (HADS),10 11 and the
Beck depression inventory, 2nd edition (BDI-II).1 12 13
In principle, a higher score on thesemeasures indicates
greater severity requiring greater intervention. How-
ever, the QOF guidance also recommends that
clinicians consider the degree of associated disability,
history of depression, and patient preference when
assessing the need for treatment rather than relying
completely on the questionnaire score.1
These measures were designed for slightly varying
purposes, and none of them is a “gold standard”
measure of depression severity. HADS is a short
screening instrument designed to identify patients with
a greater probability of depression,who should then be
further assessed with a more extended measure or a
clinical interview, rather than a measure of severity in
itself.10 BDI-II, on the other hand, was designed as a
longer measure of severity,12 and PHQ-9 was devel-
oped as both a screening instrument and a severity
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measure.14 Data on the completion of these measures
from the National Health Service Information Centre
showed that they were used in a mean of 91% of
diagnosed cases across all UK practices in 2007-8, up
from 81% in 2006-7.15 The accuracy and utility of the
measures has been questioned, however, suggesting
that, even if they use the questionnaires, practitioners
may ignore the scores when deciding about treatment
or referral.16
The aim of this study was to examine the general
practice management of patients with depression who
completed severity questionnaires, to determine
whether the use of the measures was consistent with
the rationale for their introduction—specifically
whether rates of treatment with antidepressant drugs
and referrals for psychological or psychiatric treatment
differed in line with patients’ scores on the measures.
Other potentially important predictors of intervention
—including demographic factors, history of depres-
sion, and concurrent physical illness—were also
examined to explore whether these factors seemed to
influence rates of treatment or referral as well.
The study was conducted in three sites that, between
them, served inner city, suburban, and rural areas with
varying levels of deprivation, presence of ethnic
minorities, and availability of primary care mental
health workers and psychological therapies. This
allowed us to explore the effect of site on rates of
treatment and referral.
Qualitative data on the use of themeasures were also
collected through interviewswith general practitioners
and patients and are reported separately.17
METHODS
Setting
The studywas conducted in three primary care trusts—
Southampton City, Liverpool, and Norfolk. All gen-
eral practices within Southampton City Primary Care
Trust were approached. Practices approached in
Liverpool were eithermembers of theMersey Primary
Care R&D Consortium (and therefore had an interest
in research) or were members of the Matchworks
Consortium, an informal association of practices with
an interest in mental health. Practices approached in
Norfolk were those which had previously indicated an
interest in participating in research. Interested prac-
tices were asked if they would provide anonymised
data on all patients they had assessed with the
depression severity measures between April 2006
and March 2007 inclusive.
Data collection
With the help of practices’ clerical staff and local
primary care trusts’ pharmaceutical advisers, anon-
ymised data were extracted from the computerised
medical records of patients for whom a depression
severity questionnaire score had been recorded
between April 2006 and March 2007. Data extracted
included patients’ scores recorded on the question-
naires; age and sex; concurrent physical illness; history
of depression; and subsequent management within
threemonths of completion of the questionnaire scores
(including follow-up appointments with general prac-
tice staff, antidepressant drug treatment, and referrals
for psychological, psychiatric, or social services). Data
were entered into a Microsoft Excel database and
transferred into the statistical programs SPSS, version
15, and Stata, version 10, for analysis.
Sample size
We estimated that the incidence of new diagnoses of
depression in the year would be around 1%,2 amean of
around 60 per practice, but assumed conservatively
that only about half of the affected patients would be
assessed with a severity measure.We aimed to detect a
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Fig 1 | Distributions of depression severity scores among
general practice patients with depression that was assessed
with the patient health questionnaire, 9 item version (PHQ-9)
(n=1658) or with the depression subscale of the hospital
anxiety and depression scale (HADS) (n=584)
Table 1 | Characteristics of general practice patients with depression that was assessed with
the patient health questionnaire, 9 item version (PHQ-9), or with the depression subscale of
the hospital anxiety and depression scale (HADS). Values are numbers (percentages)
Characteristic Assessed with PHQ-9 (n=1658) Assessed with HADS (n=584)
Male 593 (35.8) 208 (35.6)
Age ≥65 years 264 (15.9) 60 (10.3)
History of depression 624 (37.6) 188 (32.2)
Diabetes 147 (8.9) 32 (5.5)
Coronary heart disease 192 (11.6) 30 (5.1)
Other chronic physical illness 749 (45.2) 214 (36.6)
Recruited in Liverpool 739 (44.6) 253 (43.3)
Recruited in Southampton 656 (39.6) 294 (50.3)
Recruited in Norfolk 263 (15.9) 37 (6.3)
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15% difference in the proportion of patients treated
with antidepressants between those with mild depres-
sion and those withmoderate to severe depression. On
the basis of these assumptions, we aimed to gather data
on about 560 patients with mild depression and 280
with moderate to severe depression, from a minimum
of 28 group practices providing a mean of 30 patients
each: this would provide 90% power at the 5% level of
significance to detect the 15% difference, allowing for
an intracluster correlation coefficient of 0.05 based on
the levels typically found in primary care studies.18
Analysis
Rates of follow-up, treatment, and referrals were
analysed to determine associations with the severity
scores recorded. We compared patients in three
categories—minimal depression, mild depression,
and moderate to severe depression—using a χ2 test
with an adjustment to allow for clustering within
practices.The threshold scores formild depressionand
for moderate to severe depression were 5 and 10
respectively for the patient health questionnaire
(PHQ-9),9 14 8 and 11 respectively for the depression
subscale of the hospital anxiety and depression scale
(HADS),10 and 14 and 20 respectively for the Beck
depression inventory (BDI-II).13 The effects of the
other factorswere investigated using logistic regression
models which included, when significant, a random
effect to allow for clustering within practices. Origin-
ally, our plan was to analyse data on all patients
together, regardless of which instrument was used to
categorise the severity of their depression.
RESULTS
The numbers of practices agreeing to take part were 15
(54%)of the28approached inLiverpool, 13 (34%)of38
approached in Southampton, and 10 (38%) of 26
approached inNorfolk.Overall, 2294patients fromthe
38practiceshadadepression severity score recorded in
their records, including 1658 for PHQ-9, 584 for
HADS, and 52 for BDI-II. The mean number of
patients assessed per practice was 60.4, twice as many
as we had anticipated. PHQ-9 was used in 32 practices
(13 in Liverpool, 10 in Southampton, and 9 inNorfolk)
and HADS in 21 (8 in Liverpool, 9 in Southampton,
and 4 in Norfolk). Both measures were used in 15
practices. The number assessed with the BDI-II was
considered too small for any meaningful analysis.
Table 1 shows the characteristics of patients assessed
by the other two measures. The sample assessed with
HADS included fewer older patients, fewer patients
with recurrent depression, and fewer with concurrent
physical illness.
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Fig 2 | Distribution of depression severity among general
practice patients with depression that was assessed with the
patient health questionnaire, 9 item version (PHQ-9) (n=1658)
or with the depression subscale of the hospital anxiety and
depression scale (HADS) (n=584)
Table 2 | Management of general practice patients with depression by severity category according to the patient health questionnaire, 9 item version, (PHQ-9) or
with the depression subscale of the hospital anxiety and depression scale (HADS). Values are numbers (percentages)
Item of management received by
patient
Depression severity by PHQ-9 Depression severity by HADS
Minimal
(n=85) Mild (n=189)
Moderate to
severe (n=1384) Total (n=1658)
Minimal
(n=121) Mild (n=138)
Moderate to
severe (n=325) Total (n=584)
Follow-up appointment in ≤4 weeks 41 (48.2) 107 (56.6) 917 (65.8) 1058 (63.8)** 77 (63.6) 98 (71.0) 223 (68.6) 398 (68.2)
Prescription for an antidepressant 23 (27.1) 92 (48.7) 1195 (86.7) 1310 (79.0)*** 64 (52.9) 108 (78.3) 292 (89.9) 464 (79.5)***
Referral to mental health or social
services:
11 (12.9) 31 (16.4) 351 (25.36) 393 (23.7)** 16 (13.2) 23 (16.7) 80 (24.6) 119 (20.4)
Counsellor 6 (7.1) 18 (9.5) 197 (14.2) 221 (13.3)* 9 (7.4) 10 (7.2) 48 (14.8) 67 (11.5)
Primary care mental health worker 3 (3.5) 5 (2.6) 84 (6.1) 92 (5.5) 4 (3.3) 4 (2.9) 9 (2.8) 17 (2.9)
Psychology 1 (1.2) 2 (1.1) 22 (1.6) 25 (1.5) 1 (0.8) 6 (4.3) 14 (4.3) 21 (3.6)
Social services 0 1 (0.5) 8 (0.6) 9 (0.5) 0 1 (0.7) 1 (0.3) 2 (0.3)
Psychiatry 2 (2.4) 7 (3.7) 78 (5.6) 87 (5.2) 2 (1.6) 4 (2.9) 14 (4.3) 20 (3.4)
*P<0.05; **P<0.01; ***P<0.001 for significance of differences between severity categories (χ2 test, with adjustment for clustering by practice).
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Figure 1 shows the distribution of scores for the two
measures. The distribution was roughly normal for
both measures, although the PHQ-9 scores were
slightly more positively skewed. The mean (standard
deviation) PHQ-9 score was 15.5 (6.0) and the mean
HADS score 11.1 (4.6).
Figure 2 shows the proportions of patients in three
categories of depression severity as defined by their
scores—minimal depression (scores 0-4 with PHQ-9,
0-7 with HADS); mild (scores 5-9 with PHQ-9, 8-10
withHADS); andmoderate to severe (≥10withPHQ-9,
≥11 with HADS). With PHQ-9, 1384 (83.5%) of the
1658 patients assessed were categorised as having
moderate to severe depression (for which active
intervention is generally recommended), compared
with only 325 (55.6%) of the 584 patients assessed with
HADS.On finding these differences in the proportions
of patients classified as having moderate to severe
depression, we decided to change our plan of analysis.
Instead of analysing the data altogether regardless of
the instrument used, we carried out separate analyses
for the two main instruments.
Table 2 shows the proportions of patients, within
each category of depression severity according to
PHQ-9 and HADS, in receipt of a follow-up appoint-
ment within four weeks; a prescription for an anti-
depressant; and a referral to a counsellor, primary care
mental health worker, psychology, social services, or
psychiatry. Overall 1774 (79.1%) of 2242 patients
assessed with either measure received a prescription
for an antidepressant, and 512 (22.8%) were referred to
specialist services. Prescriptions for antidepressants
were significantly associated with greater severity of
depression for both measures. Follow-up appoint-
ments, referrals for counselling, and any referral to
specialist services were also significantly associated
with greater severity for patients assessed with PHQ-9,
but not for those assessed with HADS.
Table 3 shows odds ratios for bivariate associations
between items of management and patient character-
istics for those assessed with PHQ-9. Follow-up within
four weeks, a prescription for antidepressants, and any
referral to specialist services were significantly more
likely with moderate to severe depression compared
with minimal depression. Men were more likely to be
referred to psychiatry than women, but referrals and
antidepressant prescriptions were significantly less
likely for older patients or for patients with diabetes,
coronary heart disease, or other chronic physical
illness.
Table 4 shows odds ratios for bivariate associations
between items of management and patient character-
istics for those assessed with HADS. Again, a prescrip-
tion for antidepressants was significantly more likely
with increasing severity of depression, and there were
trends towards more referrals with increasing severity
and towards fewer antidepressant prescriptions for
older patients and for those with concurrent physical
illnesses.
Tables 3 and 4 also show that in Southampton
practices antidepressant prescriptions were signifi-
cantly more likely whereas referrals to psychology
were significantly less likely, compared with the
Liverpool and Norfolk practices. Referrals to primary
care mental health workers were significantly more
Table 3 | Bivariate associations for general practice patients with severity of depression measured with the patient health questionnaire, 9 item version, (PHQ-9)
Item of
management
received by
patient
Odds ratios (95% CI) for bivariate association
Severity†
Sex‡ Age§
History of
depression¶ Diabetes¶
Coronary
heart
disease¶
Other chronic
physical
illness¶
Recruitment centre††
Mild
Moderate to
severe Southampton Norfolk
Follow-up
appointment in
≤4 weeks
1.40 (0.84 to
2.35)
2.06 (1.33 to
3.19)**
0.87 (0.70 to
1.08)
0.77 (0.57 to
1.05)
1.01 (0.73 to
1.39)
0.86 (0.57 to
1.29)
0.60 (0.38 to
0.96)*
0.77 (0.70 to
1.09)
2.07 (1.53 to
2.80)***
1.04 (0.69 to
1.56)
Prescription
for an
antidepressant
2.56 (1.23 to
5.30)*
17.04 (7.97 to
36.43)***
0.73 (0.53 to
1.00)
0.27 (0.20 to
0.38)***
1.74 (1.22 to
2.49)**
0.26 (0.19 to
0.37)***
0.21 (0.14 to
0.33)***
0.47 (0.34 to
0.65)***
5.84 (2.93 to
11.65)***
1.08 (0.64 to
1.84)
Referral to
mental health or
social services:
1.32 (0.65 to
2.67)
2.29 (1.23 to
4.25)*
1.23 (1.01 to
1.50)*
0.32 (0.22 to
0.46)***
1.21 (0.84 to
1.78)
0.39 (0.25 to
0.66)**
0.28 (0.15 to
0.52)***
0.70 (0.56 to
0.87)**
0.72 (0.45 to
1.15)
0.64 (0.36 to
1.13)
Counsellor 1.39 (0.44 to
4.33)
2.19 (0.76 to
6.26)
0.95 (0.70 to
1.30)
0.27 (0.17 to
0.44)***
1.06 (0.64 to
1.77)
0.55 (0.29 to
1.05)
0.09 (0.03 to
0.31)***
0.71 (0.56 to
0.90)**
0.77 (0.45 to
1.31)
0.22 (0.03 to
1.44)
Primary care
mental health
worker
0.74 (0.38 to
1.46)
1.77 (0.43 to
7.27)
1.22 (0.88 to
1.70)
0.35 (0.19 to
0.67)**
1.56 (0.93 to
2.60)
0.45 (0.17 to
1.18)
0.25 (0.08 to
0.74)*
0.73 (0.45 to
1.20)
0.36 (0.10 to
1.34)
2.63 (0.73 to
9.43)
Psychology 0.90 (0.27 to
2.96)
1.36 (0.22 to
8.34)
1.20 (0.44 to
3.25)
0.46 (0.12 to
1.70)
3.00 (0.82 to
10.92)
0.42 (0.06 to
3.22)
0.31 (0.45 to
2.19)
0.47 (0.23 to
0.93)*
0.22 (0.78 to
0.63)**
0.14 (0.02 to
1.09)
Social services 1.44 (0.47 to
4.43)
0.66 (0.06 to
7.69)
0.83 (0.25 to
2.78)
0.15 (0.01 to
1.81)
7.96 (1.03 to
61.0)*
2.82 (0.23 to
33.92)
Psychiatry 1.60 (0.42 to
6.12)
2.48 (0.64 to
9.67)
2.32 (1.67 to
3.22)***
0.75 (0.36 to
1.60)
1.12 (0.64 to
1.95)
0.11 (0.02 to
0.73)*
1.11 (0.63 to
1.95)
0.85 (0.54 to
1.33)
1.04 (0.62 to
1.76)
0.53 (0.24 to
1.20)
For missing entries the odds ratio was either zero or infinity as a result of a zero cell count.
*P<0.05; **P<0.01; ***P<0.001 for significance of differences between categories. Clustering by practice taken into account for calculating 95% confidence intervals.
Comparisons: †Mild or moderate to severe v minimal. ‡Men v women. §≥65 years v <65 years. ¶Yes v no. ††Southampton or Norfolk v Liverpool.
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likely in Norfolk practices, at least among those
assessed with HADS.
Table 5 shows the results of logistic regression
analyses of factors associated with antidepressant
prescriptions or any referral to mental health or social
services to account for confounding of the various
patient and recruitment centre factors. Three factors
remained consistently significant across the two groups
of patients. A prescription for an antidepressant was
significantly more likely for patients with moderate to
severe depression on either measure, while patients
aged ≥65 years were less likely to be referred to
specialist services, and patients in Southampton
practices were more likely to be prescribed anti-
depressants than patients at the other two sites.
DISCUSSION
Main findings
The distribution of the questionnaire scores we found
represents the right hand end of the distribution which
is found when all general practice patients are
screened.19 General practitioner diagnosis of depres-
sion is associated with greater severity,4 20 and the
distribution we found is consistent with the purpose of
the quality and outcomes framework (QOF) indicator,
which encourages the use of questionnaires to assess
the severity of depression that has already been
diagnosed and is being considered for treatment rather
than to screen patients for undiagnosed depression.
Around 80% of patients assessed with either the
patient health questionnaire (PHQ-9) or the hospital
anxiety and depression scale (HADS) received
prescriptions for antidepressants, and around 20%
were referred to specialist services. In our logistic
regression analysis, a greater severity of depression
according to either measure was significantly asso-
ciated with an increased likelihood of being prescribed
an antidepressant, and being referred to specialist
services was significantly more likely for patients with
the highest scores onHADS. These findings are in line
with the rationale for the introduction of the measures.
They also accord with previous research showing that
treatment of depression in general practice is related to
greater severity of symptoms.21 However, we found
other factors to be associated with treatment and
referral, and rates of treatment and referral were not
consistent for categories of severitywhenwe compared
the two measures of depression.
Strengths and weaknesses of the study
We recruited 38 general practices, 10more than the 28
wehad aimed for, and found twice asmanypatients per
practice had been assessed with the severity ques-
tionnaires than we had anticipated, which meant we
had a much larger sample overall than we expected.
This increased the potential power of the sample.
However, this was not a random sample of general
practices as practices had to be willing to take part, so
we probably recruited practices including doctors with
a greater interest in the assessment of depression. They
may not be representative of all UK general practices,
although they were recruited from a range of locations
including inner city areas, relatively affluent suburbs,
and rural areas across the three recruitment sites,
Table 4 | Bivariate associations for general practice patients with severity of depression measured with the depression subscale of the hospital anxiety and
depression scale (HADS)
Item of
management
received by
patient
Odds ratios (95% CI) for bivariate association
Severity†
Sex‡ Age§
History of
depression¶ Diabetes¶
Coronary
heart
disease¶
Other chronic
physical
illness¶
Recruitment centre††
Mild
Moderate to
severe Southampton Norfolk
Follow-up
appointment in
≤4 weeks
1.40 (0.76 to
2.58)
1.25 (0.84 to
1.86)
1.33 (0.89 to
2.01)
1.01 (0.46 to
2.23)
0.55 (0.36 to
0.84)**
1.21 (0.58 to
2.50)
1.30 (0.43 to
0.96)
0.82 (0.51 to
1.33)
2.57 (1.74 to
3.81)***
1.55 (1.00 to
2.42)
Prescription
for an
antidepressant
3.21 (1.52 to
6.74)**
7.89 (3.51 to
17.68)**
1.08 (0.50 to
2.34)
0.52 (0.23 to
1.06)
1.26 (0.64 to
2.46)
0.47 (0.18 to
1.20)
0.36 (0.16 to
0.81)*
0.77 (0.40 to
1.48)
2.20 (1.57 to
3.06)**
0.51 (0.37 to
0.70)**
Referral to
mentalhealthor
social services:
1.31 (0.62 to
2.75)
2.14 (0.99 to
4.65)
0.64 (0.42 to
0.97)*
0.25 (0.09 to
0.75)*
1.57 (0.92 to
2.67)
0.54 (0.23 to
1.30)
0.77 (0.23 to
2.58)
0.85 (0.48 to
1.51)
0.83 (0.62 to
1.11)
1.16 (0.78 to
1.72)
Counsellor 0.97 (0.21 to
4.52)
2.15 (0.74 to
6.29)
0.63 (0.32 to
1.24)
0.12 (0.01 to
1.30)
1.49 (0.74 to
2.99)
0.50 (0.19 to
1.34)
1.20 (0.20 to
7.06)
1.11 (0.52 to
2.34)
0.54 (0.27 to
1.06)
Primary care
mental health
worker
0.87 (0.15 to
5.24)
0.83 (0.19 to
3.56)
0.75 (0.29 to
1.95)
1.17 (0.27 to
5.09)
3.12 (0.45 to
21.71)
2.39 (0.51 to
11.18)
1.16 (0.29 to
4.68)
1.22 (0.43 to
3.38)
0.12 (0.04 to
0.41)**
11.30 (3.70 to
34.35)***
Psychology 5.45 (0.61 to
48.76)
5.40 (0.37 to
78.29)
0.90 (0.68 to
1.20)
0.84 (0.48 to
1.44)
0.40 (0.21 to
0.75)**
3.82 (1.10 to
13.27)*
Social
services
Psychiatry 1.78 (0.24 to
13.20)
2.68 (0.77 to
9.35)
0.59 (0.35 to
1.02)
0.45 (0.05 to
3.92)
0.90 (0.54 to
1.50)
0.42 (0.09 to
1.92)
2.06 (0.74 to
5.71)
For missing entries the odds ratio was either zero or infinity as a result of a zero cell count.
*P<0.05; **P<0.01; ***P<0.001 for significance of differences between categories. Clustering by practice taken into account for calculating 95% confidence intervals.
Comparisons: †Mild or moderate to severe v minimal. ‡Men v women. §≥65 years v <65 years. ¶Yes v no. ††Southampton or Norfolk v Liverpool.
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including a range of levels of deprivation and differing
proportions ofminority ethnic patients. The somewhat
higher response rates amongpractices inLiverpooland
Norfolk were probably because the practices
approached there were members of groups interested
in research or mental health or both.
Our sample included too few patients assessed with
the Beck depression inventory for meaningful analysis
of that measure, so we were unable to include it.
Originally, we had intended to analyse the total sample
together, but when we found a marked difference
between the samples assessed with PHQ-9 and with
HADS in the proportions of patients classified as
having moderate to severe depression, and therefore
potentially in need of treatment, we decidedwe should
keep the analyses separate for the two instruments. The
considerably larger than expected sample size
favoured this separate analysis, but the number
assessed with HADS was only a third of the number
assessed with PHQ-9, which meant that within the
HADS samplewe had less power to identify significant
associationsbetween scores and treatment and referral,
increasing the risk of a type II error.
Findings in relation to other studies
Our logistic regression analyses showed that factors
other than measures of depression severity were
independently associated with treatment or referral.
Patients aged≥65yearswere less likely to be referred to
specialist services, which is in line with previous
research suggesting undertreatment of older people
with depression, recently highlighted by Age
Concern.22
The bivariate associations between older age and
lower rates of antidepressant treatment among patients
assessedwithPHQ-9 seemed tobeaccounted forby the
presence of diabetes or coronary heart disease when
these were considered together in the logistic regres-
sion. It seems likely that more older patients were
administered the PHQ-9, not because they were being
considered for treatment in ordinary surgeries, but
because they had been screened for depression
routinely as part of practice care for diabetes or
coronaryheart disease, as screening in those conditions
is encouraged in the quality andoutcomes framework.1
If so, it is possible that general practitioners tended to
discount depression detected on screening when
compared with depression presented to them by
patients, perhaps because of an unwillingness to
medicalise distress and label patients who were not
complaining of depression. However, we cannot be
sure this was the reason, and ideally we would need to
compare rates of treatment and referral between
patients with and without diabetes or coronary heart
disease in a sample where all patients had been
screened for depression to determine whether this
explanation is correct.
Whatever the reason, it is perhaps surprising that
patients with diabetes, coronary heart disease, and
other physical illness tended to be treated and referred
less often, despite the fact that they are known to be at
higher risk of depression, and that depression is
associated with a worse prognosis for the physical
illnesses.23-25 It seems that encouraging general practi-
tioners to screen for depression in these patients does
not lead on to them being more likely to receive
treatment than patients without diabetes or coronary
heart disease. It is possible that the practitioners were
concerned about possible drug side effects affecting the
comorbid physical problems. However this would not
explain the lower rates of referral for psychological
treatments. Another possibility is that patients with
comorbid physical conditions and multiple medica-
tions may be reluctant to accept either treatment or
referral and evenmore so if they have beendetected by
screening rather than presenting symptoms them-
selves.
A history of depressionwas associatedwith a greater
likelihood of drug treatment, at least among patients
assessedwith PHQ-9, which suggests that patients with
ahistorymaybemorewilling toconsidermedication in
light of previous experience of the illness, or general
Table 5 | Logistic regression analyses of patient and centre factors predicting drug treatment and referral for general practice patients with severity of depression
measured with the patient health questionnaire, 9 item version, (PHQ-9) or the depression subscale of the hospital anxiety and depression scale (HADS)
Item of management
received by patient
Adjusted odds ratios (95% CI) for bivariate association
Severity†
Sex‡ Age§
History of
depression¶ Diabetes¶
Coronary
heart
disease¶
Other chronic
physical
illness¶
Recruitment centre††
Mild
Moderate
to severe Southampton Norfolk
Patients assessed with PHQ-9‡‡
Prescription for an
antidepressant
1.61 (0.86 to
3.00)
8.75 (4.97 to
15.44)***
0.94 (0.70 to
1.27)
0.79 (0.53 to
1.18)
1.51 (1.11 to
2.06)**
0.57 (0.37 to
0.87)*
0.54 (0.35 to
0.83)**
0.82 (0.60 to
1.11)
5.37 (3.12 to
9.24)***
1.37 (0.81 to
2.30)
Referral to mental health
or social services
1.17 (0.53 to
2.58)
1.63 (0.81 to
3.30)
1.39 (1.09 to
1.79)**
0.50 (0.31 to
0.80)**
0.99 (0.77 to
1.27)
0.51 (0.29 to
0.89)*
0.40 (0.23 to
0.71)**
0.82 (0.64 to
1.06)
0.62 (0.39 to
0.97)
0.68 (0.41 to
1.14)
Patients assessed with HADS
Prescription for an
antidepressant
2.87 (1.64 to
5.03)***
6.55 (3.84 to
11.18)***
1.09 (0.68 to
1.73)
1.23 (0.55 to
2.74)
1.42 (0.86 to
2.35)
0.52 (0.22 to
1.24)
0.68 (0.26 to
1.78)
0.93 (0.58 to
1.61)
1.69 (1.06 to
2.69)*
0.54 (0.25 to
1.17)
Referral to mental health
or social services
1.39 (0.68 to
2.84)
2.35 (1.26 to
4.37)**
0.60 (0.38 to
0.95)*
0.18 (0.05 to
0.60)**
1.35 (0.85 to
2.15)
0.69 (0.22 to
2.20)
1.98 (0.61 to
6.44)
0.76 (0.47 to
1.25)
0.64 (0.39 to
1.07)
1.60 (0.66 to
3.89)
*P<0.05; **P<0.01; ***P<0.001 for significance of differences between categories.
Comparisons: †Mild or moderate to severe v minimal. ‡Men v women. §≥65 years v <65 years. ¶Yes v no. ††Southampton or Norfolk v Liverpool.
‡‡Significant random effect included to allow for clustering by practice.
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practitioners may be more willing to prescribe for
them, or both.
Thereweredifferences in treatmentandreferral rates
between recruitment sites, whichmay be explained by
local circumstances. Patients in Southampton practices
weremore likely to be prescribed antidepressants than
patients at the other two sites, which is consistent with
prescribing analyses and cost data from the Prescrip-
tion Pricing Authority26 showing that Southampton
practices were relatively high prescribers of anti-
depressants. The averagedaily quantity use of selective
serotonin reuptake inhibitors was 2150.15 per 1000
“age, sex and temporary resident originated prescrib-
ing units” in SouthamptonCity PrimaryCare Trust for
the second quarter of 2006 compared with 1529.69 for
England (personal communication Julie Mulvihill,
prescribing support technician, Southampton City).
At the time covered by our study data, psychological
services and counselling had longer waiting lists in
Southampton than in Liverpool and Norfolk, which
may explain the differences in treatment rates, as
general practitioners probably prescribe anti-
depressants more often if specialist psychological
treatment is less readily available.
Meaning of the study and implications for practice
The proportion of patients categorised as having
moderate to severe depression was 83.5% for those
assessed with PHQ-9 compared with only 55.6% for
those assessed with HADS. Despite this large differ-
ence in classification of patients, the general practi-
tioners prescribed antidepressants to a similar
proportion of patients assessed with either measure,
which suggests that the score on the measure was not
the defining factor in the decision to prescribe. It is
likely that the practitioners usually decided on treat-
ment on the basis of their clinical judgment, taking into
account other factors besides the symptom count—
such as the degree of associated impairment, a history
of depression, and previous treatment with anti-
depressants. This explanation is supported by the
findings of the qualitative interviews of participating
general practitioners which suggested that they usually
used their clinical judgment to decide on treatment and
wereonly occasionally influencedby thequestionnaire
scores.17 Future research could address this issue by
asking practitioners to rate their certainty of diagnosis
and need for treatment before administering the
instruments.
Research suggests that general practitioners’ catego-
rical assessments of patients often differ from those of
questionnaire measures.4 7 The question then is which
is more accurate in terms of predicting the need for
treatment, general practitioners’ clinical judgment or
questionnaire measures? Previous research into con-
comitant administration, to a single sample of patients,
of the two measures included in this study found that a
greater proportion of the sample was classified as
having moderate to severe depression according to
PHQ-9 than according to HADS.27
It should be emphasised that neither of the two
measures is an optimum measure of the severity of
depression, and scores above the recommendedcut-off
values giveonly an indication that aparticular patient is
likely to have major depressive disorder. Recent
validation studies against more extensive diagnostic
assessments have suggested that the accuracy of the
measures in predicting major depressive disorder
could be improved by using a more conservative cut-
off score of 12 rather than 10 with PHQ-9628 and a less
conservative cut-off score of 9 rather than 11 with
HADS.6 In our sample 76.1%of patients scored ≥12 on
PHQ-9 and 72.6%of patients scored ≥9 onHADS, so if
these two cut-off values had been used a similar
proportion of patients would have been classified as
having moderate to severe depression by the two
instruments. These proportions would also be more in
line with the general practitioners’ rates of treatment,
and so changing the recommended cut-off scores in
these ways might make the scores more valid, more
consistent with practitioners’ clinical judgment, and
therefore more acceptable to practitioners as a way of
classifying patients.
Both PHQ-9 and HADS were used in some of the
participating practices, so even within group practices
it seems that doctors may differ in terms of their
instrument of choice. This is an argument for retaining
the option of using a number of severity measures
within the quality and outcomes framework, as long as
greater consistency in classifying mild and moderate
depression can be achieved.
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